Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · IEX Real-Time Price · USD
37.38
-1.43 (-3.68%)
At close: Jul 2, 2024, 4:00 PM
37.75
+0.37 (0.99%)
After-hours: Jul 2, 2024, 4:47 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $6.17 billion as of July 2, 2024. Its market cap has increased by 127.31% in one year.
Market Cap
6.17B
Enterprise Value
4.55B
1-Year Change
127.31%
Ranking
Category
Stock Price
$37.38
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.53B to $6.17B, an increase of 303.37%. That is a compound annual growth rate of 37.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 6.40B | 103.77% |
| Dec 29, 2023 | 3.14B | 48.57% |
| Dec 30, 2022 | 2.12B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 71.89% |
| Feb 13, 2020 | 1.53B | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jazz Pharmaceuticals | 6.62B |
| Ionis Pharmaceuticals | 6.62B |
| Halozyme Therapeutics | 6.50B |
| Exelixis | 6.45B |
| Cytokinetics | 6.22B |
| Acadia Healthcare Company | 6.06B |
| Masimo | 6.03B |
| Glaukos | 6.02B |